Capitalization 42.85B 5.97B 5.12B 4.77B 4.44B 8.19B 514B 9.15B 57.65B 21.76B 241B 22.39B 21.93B 886B P/E ratio 2025 *
21.3x
P/E ratio 2026 * 18x
Enterprise value 41.26B 5.75B 4.93B 4.59B 4.27B 7.89B 495B 8.81B 55.5B 20.95B 232B 21.55B 21.11B 853B EV / Sales 2025 *
8.03x
EV / Sales 2026 * 6.64x
Free-Float
38.88%
Yield 2025 *
2.53%
Yield 2026 * 2.93%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.33%
1 week-1.18%
Current month-3.84%
1 month-6.66%
3 months+6.46%
6 months-10.79%
Current year-23.02%
More quotes
1 week 53.35
Extreme 53.35
55.46
1 month 53.35
Extreme 53.35
58.77
Current year 49.01
Extreme 49.01
71.4
1 year 49.01
Extreme 49.01
97.2
3 years 33.42
Extreme 33.42
97.2
5 years 31.76
Extreme 31.76
107.41
10 years 19.83
Extreme 19.8263
107.41
More quotes
Manager TitleAgeSince
Chief Executive Officer 61 2012-08-16
Director of Finance/CFO 50 2012-08-16
Human Resources Officer 32 2021-04-30
Director TitleAgeSince
Chairman 61 2012-08-16
Director/Board Member 62 2018-09-09
Director/Board Member 50 2012-07-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.33%-1.18%-17.98%+26.57% 5.97B
+0.08%-0.75%+25.29%+14.45% 16.27B
-3.50%+13.88% - - 8.39B
-1.73%-7.54%+51.09%+0.06% 5.76B
+0.33%-0.15%-11.10%-31.54% 5.68B
-4.65%-13.69%-39.91%-1.82% 4.86B
+0.63%+1.16%-12.32%-16.87% 3.05B
+2.06%+7.04%-3.35%-30.77% 2.43B
-1.34%-4.30%-37.34%-51.22% 1.96B
-0.61%+3.00%+13.18%-25.77% 1.7B
Average -0.84%-0.35%-3.60%-12.99% 5.61B
Weighted average by Cap. -0.95%+0.07%+5.13%-1.36%
See all sector performances

Financials

2025 *2026 *
Net sales 5.14B 716M 614M 572M 532M 982M 61.65B 1.1B 6.91B 2.61B 28.91B 2.69B 2.63B 106B 6.09B 848M 728M 678M 631M 1.16B 73.03B 1.3B 8.19B 3.09B 34.24B 3.18B 3.11B 126B
Net income 2.01B 280M 240M 224M 208M 384M 24.09B 429M 2.7B 1.02B 11.3B 1.05B 1.03B 41.52B 2.42B 338M 290M 270M 251M 463M 29.07B 517M 3.26B 1.23B 13.63B 1.27B 1.24B 50.1B
Net Debt -1.6B -222M -191M -178M -165M -305M -19.16B -341M -2.15B -811M -8.98B -835M -817M -33.02B -2.44B -340M -292M -272M -253M -467M -29.29B -521M -3.28B -1.24B -13.73B -1.28B -1.25B -50.48B
More financial data * Estimated data
Logo Shenzhen New Industries Biomedical Engineering Co., Ltd.
Shenzhen New Industries Biomedical Engineering Co Ltd is a company engaged in research and development, production and sales of in-vitro diagnostics instruments and supporting reagents. The Company operates three segments, including Instruments and Supporting Software, Reagents, Accessories and Others. Instruments and Supporting Software segment is involved in the production and sales of MAGLUMI automatic chemiluminescence immunoassay analyzer series products and Biossays automatic biochemical analyzer series products. Reagents segment operates the sales of supporting reagents for the analyzers. The products are applied in the examination of Gonads, thyroid gland, glucose metabolism, kidney function and so on. Accessories and Others segment is responsible for the manufacturing and sales of accessories related to in-vitro diagnostics equipment. The Company sells its products both in domestic and international markets, including Asia, Europe, America and Africa.
Employees
2,841
More about the company
Date Price Change Volume
25-07-18 54.54 ¥ +0.33% 3,000,111
25-07-17 54.36 ¥ +0.98% 2,851,294
25-07-16 53.83 ¥ -0.09% 4,124,180
25-07-15 53.88 ¥ -1.66% 4,198,464
25-07-14 54.79 ¥ -0.72% 1,771,649

End-of-day quote Shenzhen S.E., July 17, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
54.54CNY
Average target price
68.92CNY
Spread / Average Target
+26.37%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300832 Stock